Compounds for treating spinal muscular atrophy
US10501482B2 · kind B2 · utility
2Cited by
1References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 9, 2018 |
| Grant date | Dec 10, 2019 |
| Priority date | — |
| Expiry date | Apr 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I) wherein A, B, X, Y, R1 and R2 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.